Cargando…
Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells
p300/CBP histone acetyltransferases (HAT) are critical transcription coactivators involved in multiple cellular activities. They act at multiple levels in non-small cell lung carcinoma (NSCLC) and appear, therefore, as promising druggable targets. Herein, we investigated the biological effects of A-...
Autores principales: | Ansari, Mohammad Salik Zeya, Stagni, Venturina, Iuzzolino, Angela, Rotili, Dante, Mai, Antonello, Del Bufalo, Donatella, Lavia, Patrizia, Degrassi, Francesca, Trisciuoglio, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842509/ https://www.ncbi.nlm.nih.gov/pubmed/36117234 http://dx.doi.org/10.1038/s41417-022-00524-8 |
Ejemplares similares
-
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022) -
Protein Lysine Acetylation
by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015) -
First-in-Class
Inhibitors of the Ribosomal Oxygenase
MINA53
por: Nowak, Radosław P., et al.
Publicado: (2021) -
First-in-Class
Selective Inhibitors of the Lysine
Acetyltransferase KAT8
por: Fiorentino, Francesco, et al.
Publicado: (2023) -
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells
por: Negri, Aide, et al.
Publicado: (2023)